Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Functional recovery in parkinsonian monkeys treated with GDNF

Abstract

PARKINSON 's disease results from the progressive degeneration of dopamine neurons that innervate the striatum1,2. In rodents, glial-cell-line-derived neurotrophic factor (GDNF) stimulates an increase in midbrain dopamine levels, protects dopamine neurons from some neurotoxins, and maintains injured dopamine neurons3–9. Here we extend the rodent studies to an animal closer to the human in brain organization and function, by evaluating the effects of GDNF injected intracerebrally into rhesus monkeys that have had the symptomatology and pathophysiological features of Parkinson's disease induced by the neurotoxin 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)10–14. The recipients of GDNF displayed significant improvements in three of the cardinal symptoms of parkinsonism: bradykinesia, rigidity and postural instability. GDNF administered every four weeks maintained functional recovery. On the lesioned side of GDNF-treated animals, dopamine levels in the midbrain and globus pallidus were twice s high, and nigral dopamine neurons were, on average, 20% larger, with an increased fibre density. The results indicate that GDNF may be of benefit in the treatment of Parkinson's disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jellinger, K. Adv. Neurol. 45, 1–18 (1986).

    Google Scholar 

  2. Hornykiewicz, O. & Kish, S. J. Adv. Neurol. 45, 19–34 (1986).

    Google Scholar 

  3. Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. & Collins, F. Science 260, 1130–1132 (1993).

    Article  ADS  CAS  Google Scholar 

  4. Beck, K. D. et al. Nature 373, 339–341 (1995).

    Article  ADS  CAS  Google Scholar 

  5. Bowenkamp, K. E. et al. J. comp. Neurol. 355, 479–489 (1995).

    Article  CAS  Google Scholar 

  6. Hoffer, B. J. et al. Neurosci. Lett. 182, 107–111 (1994).

    Article  CAS  Google Scholar 

  7. Hudson, J. et al. Brain Res. Bull. 36, 425–432 (1995).

    Article  CAS  Google Scholar 

  8. Tomac, A. et al. Nature 373, 335–339 (1995).

    Article  ADS  CAS  Google Scholar 

  9. Kearns, C. M. & Gash, D. M. Brain Res. 672, 104–111 (1995).

    Article  CAS  Google Scholar 

  10. Ovadia, A., Zhang, Z. & Gash, D. M. Neurobiol. Aging 16, 931–937 (1995).

    Article  CAS  Google Scholar 

  11. Gash, D. M. et al. J. comp. Neurol. 363, 345–358 (1995).

    Article  CAS  Google Scholar 

  12. Bankiewicz, K. S. et al. Life Sci. 39, 7–16 (1986).

    Article  CAS  Google Scholar 

  13. Bankiewicz, K. S., Mandel, R. J. & Sofroniew, M. V. Expl Neurol. 124, 140–149 (1993).

    Article  CAS  Google Scholar 

  14. Smith, R. D., Zhang, Z., Kurlan, R., McDermott, M. & Gash, D. M. Neuroscience 52, 7–16 (1993).

    Article  CAS  Google Scholar 

  15. DeLong, M. R. Trends Neurosci. 13, 281–289 (1990).

    Article  CAS  Google Scholar 

  16. Robertson, G. S. & Robertson, H. A. Neurosci. Lett. 89, 204–208 (1988).

    Article  CAS  Google Scholar 

  17. Robertson, G. S. & Robertson, H. A. J. Neurosci. 9, 3326–3331 (1989).

    Article  CAS  Google Scholar 

  18. Dougle, K. L. & Crocker, A. D. Proc. natn. Acad. Sci. U.S.A. 92, 1669–1673 (1995).

    Article  ADS  Google Scholar 

  19. Greenamyre, J. T. et al. Ann. Neurol. 35, 655–661 (1994).

    Article  CAS  Google Scholar 

  20. Coggeshall, R. E. Trends Neurosci. 15, 9–13 (1992).

    Article  CAS  Google Scholar 

  21. West, M. J. Neurobiol. Aging 14, 275–285 (1993).

    Article  CAS  Google Scholar 

  22. Harding, A. J., Halliday, G. M. & Cullen, K. J. Neurosci. Meth. 51, 83–89 (1994).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gash, D., Zhang, Z., Ovadia, A. et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252–255 (1996). https://doi.org/10.1038/380252a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/380252a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing